Please assess the completion status of the following clinical trial:

Trial Title: Randomized Trial of IN.PACT Admiral® Drug Coated Balloon vs Standard PTA for the Treatment of SFA and Proximal Popliteal Arterial Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
General Inclusion Criteria:~* Age ≥18 years and ≤85 years~* Patient or patient's legal representative is informed of the nature of the study, agrees to participate and has signed an EC approved consent form~Angiographic Inclusion Criteria:~- Target vessel is the superficial femoral artery and/or proximal popliteal artery (above the knee)~General Exclusion Criteria:~* Patient unwilling or unlikely to comply with follow-up schedule~* Stroke or STEMI within 3 months prior enrolment~Angiographic Exclusion Criteria:~- Acute or sub-acute thrombus in the target vessel

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Drug-Coated Balloon (DCB) (Type: EXPERIMENTAL): IN.PACT Admiral: Balloon Angioplasty
- Standard PTA (Type: ACTIVE_COMPARATOR): Standard Percutaneous Transluminal Angioplasty (PTA) Balloon: Balloon Angioplasty

Based on this trial design, predict the completion outcome and termination type (if applicable).